Noor Mastura Mohd Mujar

Dr. Noor Mastura Mohd Mujar


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2021 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
KTKing Fang Tan
King Fang Tan
FAFarzaana Adam
Farzaana Adam
HHHasmah Hussin
Hasmah Hussin
NMNoor Mastura Mohd Mujar
Noor Mastura Mohd Mujar
This study compared breast cancer survival and the prognostic factors across different age groups of women in Penang, Malaysia. Data on 2,166 women with breast cancer who had been diagnosed between 2010 and 2014 were extracted from the Penang Breast Cancer Registry and stratified into 3 age groups: young (< 40 years old), middle-aged (40-59 years old), and elderly (≥ 60 years). The overall and relative survival rates were calculated using the life table method, median survival time was calculated using the Kaplan-Meier method, and comparisons between groups were conducted using the log-rank test. Prognostic factors were analyzed using a Cox proportional hazards model. The 5-year overall and breast cancer-specific survival rates for women with breast cancer in Penang were 72.9% and 75.2%, with a mean survival time of 92.5 months and 95.1 months, respectively. The 5-year breast cancer-specific survival rates for young, middle-aged, and elderly women were 74.9%, 77.8%, and 71.4%, respectively, with a mean survival time of 95.7 months, 97.5 months, and 91.2 months. There was a significant difference in breast cancer survival between age groups, with elderly women showing the lowest survival rate, followed by young and middle-aged women. Disease stage was the most prominent prognostic factor for all age groups. Survival rates and prognostic factors differed according to age group. Treatment planning for breast cancer patients should be age-specific to promote better cancer care and survival.

14 March 2022 in JCO Global Oncology
Verified
Journal Article
Open access
NMNoor Mastura Mohd Mujar
Noor Mastura Mohd Mujar
MDMaznah Dahlui
Maznah Dahlui
NENor Aina Emran
Nor Aina Emran
IHImisairi Abdul Hadi
Imisairi Abdul Hadi
YYYang Wai Yan
Yang Wai Yan
NTNur Aishah Taib
Nur Aishah Taib
PURPOSE: The aim of this study is to determine the pathway that women follow for Breast Cancer Care (BCC) and the time intervals from symptom discovery to treatment initiation and to develop a quality matrix framework. METHODS: A retrospective cohort study was conducted at six tertiary centers in Malaysia. All women with newly diagnosed breast cancer were interviewed, and a medical records review was conducted using a structured questionnaire. The BCC timeliness framework showed that the total time between a woman discovering their first breast changes and the date of initial treatment was divided into three distinct intervals: presentation interval, diagnostic interval, and treatment interval. Four diagnosis subintervals, referral, biopsy, report, and diagnosis resolution intervals, were also looked into. RESULTS: The BCC timeliness framework was used to capture important time points. The median total time, presentation interval, diagnostic interval, and treatment interval were 4.9 months (range, 1 month to 10 years), 2.4 months (range, 7 days to 10 years), 26 days (range, 4 days to 9.3 months), and 21 days (range, 1 day to 7.2 months), respectively. Meanwhile, the median time for the diagnosis subinterval of referral, biopsy, report, and diagnosis resolution was 8 days (range, 0 day to 8 months), 0 day (range, 0 day to 20 days), 7 days (range, 3 days to 3.5 months), and 4 days (range, 1 day to 1.8 months), respectively. CONCLUSION: The BCC timeliness framework is based on the current sequenced trajectory of the BCC journey. Clarity in the measurement of timeliness provides a standardized language for monitoring and outcome research. It can serve as a quality indicator for community and hospital-based breast cancer programs.

1 February 2026 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
PRPutri Rhamelani
Putri Rhamelani
WRWindy Rakhmawati
Windy Rakhmawati
SFSiti Yuyun Rahayu Fitri
Siti Yuyun Rahayu Fitri
NMNoor Mastura Mohd Mujar
Noor Mastura Mohd Mujar
Drug-Resistant Tuberculosis (DR-TB) in children remains highly prevalent and requires long-term treatment. Parental involvement is crucial in preventing DR-TB in children, but often faces various challenges. This review aims to describe and analyze research on factors related to parental involvement in DR-TB prevention efforts in children. This study used a scoping review design following the JBI scoping review guidelines. The literature search used five primary databases, including PubMed, ScienceDirect, Scopus, Sage Journals, and Taylor & Francis. Inclusion criteria included articles focusing on parental involvement in DR-TB prevention in children and its factors, written in English, original research, and published between 2010 and 2025. Exclusion criteria included review articles and research protocols. Based on the results of the literature review, we analyzed 14 relevant articles. Efforts to prevent DR-TB in children include preventing exposure to DR-TB in children in the household and preventing active TB treatment failure in children. There are various factors related to parental involvement through DR-TB preventive therapy in children as a representation of emotional support (stigma, support from health workers, concerns, family openness), instrumental or logistical (logistical burden factors, economic, concurrent treatment with parents, side effects), informational (level of knowledge, level of awareness), and appraisal (trust in the health system). Meanwhile, parental involvement in efforts to provide TB treatment to children represents emotional support (stigma factors, psychosocial burden, attitudes of health workers, concerns, motivation, community support, child gender), instrumental or logistical (factors of access to health services, economic, difficulty administering drugs, age and gender of parents, drug side effects, child age, ability to provide nutritious food, child character), informational (educational factors, education level, knowledge level), and appraisal (trust in health services). These findings suggest that strengthening parental support through tailored health education, counseling, and close collaboration with health workers is crucial to prevent DR-TB in children.

4 August 2022 in Nursing & Health Sciences
Verified
Journal Article
Closed access
NONelson Chidinma Okpua
Nelson Chidinma Okpua
RHRohayu Hami
Rohayu Hami
CEChidinma Oswald Edeogu
Chidinma Oswald Edeogu
NMNoor Mastura Mohd Mujar
Noor Mastura Mohd Mujar

9 January 2026 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
NMNoor Mastura Mohd Mujar
Noor Mastura Mohd Mujar
MMMuhamad Sharan Musa
Muhamad Sharan Musa
PRPuteri Norliza Megat Ramli
Puteri Norliza Megat Ramli
Chemotherapy-induced alopecia (CIA) remains a distressing side effect of cancer treatment, affecting patients’ quality of life and psychological well-being. Scalp cooling is a promising intervention to prevent hair loss, yet challenges related to cost, accessibility, and environmental impact limit its widespread adoption. This narrative systematic review analyzed 52 studies published between 2014 and 2024 on innovations in scalp cooling technologies, focusing on cost-effectiveness, sustainability, and accessibility for low-income cancer patients. Findings indicate that gel-based, cryogel, and silicone-based cooling caps offer practical, affordable alternatives to machine-operated systems, while biodegradable and recyclable materials enhance environmental sustainability. Additionally, solar-powered and reusable designs show potential for use in low-resource settings. Overall, evidence suggests that affordable and eco-friendly scalp cooling solutions can significantly improve equity in cancer care by making hair-preserving interventions more accessible and sustainable.

6 June 2023 in Journal of Health and Translational Medicine
Verified
Journal Article
Open access
PDF file
NONelson Chidinma Okpua
Nelson Chidinma Okpua
NSNoorsuzana Mohd Shariff
Noorsuzana Mohd Shariff
RHRohayu Hami
Rohayu Hami
NMNoor Mastura Mohd Mujar
Noor Mastura Mohd Mujar
Epidemiological evidences over the decades suggest that about 60% to 75% of emerging human infectious diseases are transmitted by animals, especially wildlife. This is as a result of the increasing interface between human, wild animals and environment caused by the destruction of natural habitats by human activities and climate change. The recent link of COVID-19 to the seafood and animals’ market in Wuhan China, and the 98.99% shared resemblance of the virus to the genetic sequence of bat coronavirus holds a strong suspicion for zoonotic transmission. However, efforts towards controlling the pandemic have been centered on human health, with little or no attention on the animal and environment hosts. This paper proposes one health approach as a strategy that could control the resurgence of COVID-19 and similar zoonotic diseases outbreak.